跳至主要内容
临床试验/ACTRN12618001155280
ACTRN12618001155280进行中(未招募)未知

EX-HEART TRIAL: Evaluating the impact of exercise on cardiac remodeling in men with prostate cancer undergoing androgen deprivation therapy

Australian Catholic University0 个研究点目标入组 41 人开始时间: 2018年7月13日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
41

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
40 Years 至 o limit(—)
性别
Male

入选标准

  • The inclusion criteria for the prostate cancer group are:
  • Histologically confirmed prostate cancer
  • 40 years and older
  • Currently receiving or scheduled to receive androgen deprivation therapy (<1 month of initiating therapy) with or without upfront chemotherapy
  • Additionally, 10 aged-matched control participants will be recruited to assess the trajectory of change in cardiovascular function. Men will be included if they are male and have not been diagnosed with cancer.

排除标准

  • The exclusion criteria for the prostate cancer group and age-matched control are:
  • Unstable heart condition determined by study doctor and/or general practitioner
  • Previously received ADT or chemotherapy for the treatment of a previous cancer
  • Acute illness or any musculoskeletal, cardiovascular or neurological disorder that
  • could inhibit exercise or put participants at risk during exercise testing
  • A contraindication to cardiac magnetic resonance imaging is a metallic implant or cardiac pacemaker

研究者

相似试验